Fergus Quigley

Director, Device Development Leader (Combination Product Development) @Takeda

Lexington, MA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jan 2019 — Present

Director, Device Development Leader (Combination Product Development) @Takeda

View department →

Boston, MA, US

Lead combination device function/activity for early stage programs for device enabled (neurosurgery) single time drug delivery for treatment of neurodegenerative diseases. Additionally, lead exploratory device development for select programs requiring chronic drug delivery, intra-CSF delivery and less common routes of administration. Current focus on combination device development for systemic (SC) drug delivery with a cross-functional team.

EDUCATION

1987 — 1991

University of Limerick

Bachelor of Engineering (B.Eng.), Materials Engineering

1991 — 1995

University of Limerick

Doctor of Philosophy (Ph.D.)

SKILLS

Design ControlR&DMedical DevicesFdaBiomedical EngineeringIso 13485CapaV&VDesign of ExperimentsCross-Functional Team LeadershipQuality SystemProduct DevelopmentSolidworksDesign ValidationProduct Launch

ABOUT FERGUS QUIGLEY

Over 20-years’ experience in medical device development providing technical and strategic leadership with differentiation.Experienced in permanent implants for vascular, endovascular, pulmonary, soft tissue and surgical application. Experienced in mechanical sub-systems for radiation oncology (SRS, SBRT). Experienced in electrosurgery devices (RF, acoustic) and advanced instruments for open, laparoscopic and MIS surgery. Rapidly explored technology and demonstrated differentiated performance. Identified cross-platform business opportunities to fill a multi-year pipeline to meet clinical and business needs.Current focus is on drug delivery via combination device development for systemic drug delivery. Recent work includes establishing the strategy and demonstrating efficient drug delivery to small and large structures in the brain, intra-CSF drug delivery (ICV, ICM, IT), all for treatment of a range of neurodegenerative diseases. Exploration of transdermal and intranasal drug delivery.Track record developing high performance teams, providing cross-functional leadership, incubating technology, translation to/execution of research plans. Driven, ambitious and passionate.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Fergus Quigley — Director, Device Development Leader (Combination Product Development) at Takeda in Lexington, MA, US | Unifers